Top story

RFK Jr. to Allow Broad Use of Unapproved Peptide Injections

In a unilateral declaration by the health secretary, several injections promoted by online influencers will become widely available. The F.D.A. had advised against the move.

Read full story

RFK Jr. to Allow Broad Use of Unapproved Peptide Injections

The New York Times - Drugs & Pharmaceuticals

By Christina Jewett - Wed, 28 Oct 2026

Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

The New York Times - Drugs & Pharmaceuticals

By Gina Kolata - Wed, 30 Sep 2026

New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?

The New York Times - Drugs & Pharmaceuticals

By Gina Kolata - Wed, 30 Sep 2026

A.I. Is ‘Better Informed’ Than Doctors, Kennedy Tells Industry-Backed MAHA Summit

The New York Times - Drugs & Pharmaceuticals

By Sheryl Gay Stolberg - Wed, 30 Sep 2026

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

The New York Times - Drugs & Pharmaceuticals

By Gina Kolata, Rebecca Robbins and Carolyn Y. Johnson - Wed, 26 Aug 2026

Trump Will End Subsidies for Medicare Drug Premiums

The New York Times - Drugs & Pharmaceuticals

By Rebecca Robbins and Reed Abelson - Wed, 29 Jul 2026

Shortage of Chemotherapy Drugs Brings Rationing Fears for Cancer Patients

The New York Times - Drugs & Pharmaceuticals

By Christina Jewett - Wed, 24 Jun 2026

Monthly News Roundup - December 2025

Drugs.com - News for Health Professionals

Wed, 31 Dec 2025

Why Your Gut May Stall Out And What To Do About It

Drugs.com - Daily MedNews

Wed, 31 Dec 2025